说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 持续静脉注射
1)  continuous infusion
持续静脉注射
1.
L-OHP:75mg/m~2, iv infusios 3 hours,d1,8; LV 100mg/m~2,iv infusion d1-5;VP-16:100mg,iv infusion d1-3;5-FU 500mg/m~2 mcontinuous infusion 120 hours 3-4 weeks is a cycle.
目的观察草酸铂(L-OHP)联合持续静脉注射5-FU为主方案治疗晚期胃癌近期疗效观察。
2)  Continuous infusion
持续静脉输注
1.
Efficacy of high dose furosemide with continuous infusion,single or double injection in refractory heart failure;
大剂量呋塞米持续静脉输注与单次及分次静脉注射在难治性心力衰竭治疗中的疗效观察
2.
Clinical observation on continuous infusion of home-made vinorelbine with cisplatin for management of advanced or metastatic non-small cell lung cancer;
异长春花碱持续静脉输注治疗晚期非小细胞肺癌的临床观察
3.
Objective To study the clinical response and toxic - side reactions of 39 patients with advanced gastrointestinal carcinoma treated with continuous infusion of fluorouracil CF,DDP,10 - HCPT.
目的 研究氟脲嘧啶(5-Fu)持续静脉输注联合亚叶酸钙(CF)、10-羟基喜树碱(10-HCPT)、顺铂(DDP)(HLFP)方案治疗晚期胃肠道癌的疗效和毒副反应。
3)  continuous intravenous infusion
持续静脉输注
1.
Comparison of different kinds of opioids with propofol through continuous intravenous infusion in intracranial surgery;
颅内手术中异丙酚联合不同阿片类药物持续静脉输注的疗效比较
2.
Objective: To evaluate the efficacy quality of life and tolerance of 5-Fu continuous intravenous infusion combined with octreotide in the treatment of advanced primary hepatic cancer.
目的 评价5-Fu持续静脉输注联合奥曲肽治疗晚期原发性肝癌(PHC)的疗效、对生活质量的改善及其耐受性。
4)  Continuous infusion
持续静脉滴注
5)  continuous intravenous infusion
静脉持续输注
1.
Objective To determine the efficacy of epirubicin(EADM),vincristine(VCR) and etoposide(VP16) administered as a 96 h continuous intravenous infusion in patients with refractory non Hodgkin′s lymphoma(NHL),and to evaluate the reversibility of EADM resistance in human leukemia cell lines K562.
目的 观察表阿霉素 (EADM )、长春新碱 (VCR)、足叶乙甙 (VP 1 6)静脉持续输注治疗难治性恶性淋巴瘤的临床疗效 ,通过实验室研究探讨低浓度EADM对肿瘤细胞耐药的影响。
6)  intravenous drip
持续静脉内滴注
补充资料:静脉注射


静脉注射


将药液或血液注入静脉中。注射部位常为四肢浅静脉,小儿头皮静脉等。静脉注射的目的是:①使药物较肌肉注射更迅速地发挥作用,特别适用于危重病人的抢救;②药物不宜采取其它方法给药时;③用作诊断或试验,如肝、肾、胆囊、静脉造影,心电图,阿托品试验等,④小量的静脉输血。但应注意:注射液必须澄明、无菌、无热原和无异物,也不引起凝血和溶血作用;静脉注射速度一般应较缓慢;药液勿溢漏出血管外,特别是高渗溶液和某些刺激性药物。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条